SIMILAR PATTERNS OF AMINO ACIDS FOR 1LBC_C_CYZC331_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dmu BGLI RESTRICTION
ENDONUCLEASE

(Bacillus
subtilis) 		PF14562
(Endonuc_BglI) 		5 ILE A 288
PRO A 290
LEU A 285
SER A 239
LEU A  35
 None
 1.37A 1lbcA-1dmuA:
undetectable
1lbcC-1dmuA:
undetectable		 1lbcA-1dmuA:
23.81
1lbcC-1dmuA:
23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jya YOPE REGULATOR

(Yersinia
pseudotuberculosis) 		PF05932
(CesT) 		5 ILE A  73
PRO A  94
LEU A  74
SER A 102
LEU A  98
 None
 1.43A 1lbcA-1jyaA:
undetectable
1lbcC-1jyaA:
undetectable		 1lbcA-1jyaA:
17.74
1lbcC-1jyaA:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1m9i ANNEXIN VI

(Homo sapiens) 		PF00191
(Annexin) 		5 ILE A 500
SER A 490
LEU A 504
LEU A 485
LYS A 483
 None
 1.44A 1lbcA-1m9iA:
undetectable
1lbcC-1m9iA:
undetectable		 1lbcA-1m9iA:
18.29
1lbcC-1m9iA:
18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1upf URACIL
PHOSPHORIBOSYLTRANSF
ERASE

(Toxoplasma
gondii) 		no annotation 5 ILE D 233
PRO D 165
SER D 116
LEU D 196
LEU D  73
 None
 1.34A 1lbcA-1upfD:
undetectable
1lbcC-1upfD:
undetectable		 1lbcA-1upfD:
19.15
1lbcC-1upfD:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vf6 MAGUK P55 SUBFAMILY
MEMBER 5

(Mus musculus) 		PF09060
(L27_N) 		5 ILE C 147
SER C 129
LYS C 132
LEU C 150
LEU C 127
 None
 1.30A 1lbcA-1vf6C:
undetectable
1lbcC-1vf6C:
undetectable		 1lbcA-1vf6C:
11.79
1lbcC-1vf6C:
11.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zb7 NEUROTOXIN

(Clostridium
botulinum) 		PF01742
(Peptidase_M27) 		5 ILE A 314
SER A 317
LEU A 119
LEU A 303
LYS A 336
 None
 1.40A 1lbcA-1zb7A:
undetectable
1lbcC-1zb7A:
undetectable		 1lbcA-1zb7A:
21.29
1lbcC-1zb7A:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qzu PUTATIVE SULFATASE
YIDJ

(Bacteroides
fragilis) 		PF00884
(Sulfatase) 		5 ILE A 346
SER A  61
PRO A 343
LEU A 340
LEU A  59
 None
 1.40A 1lbcA-2qzuA:
undetectable
1lbcC-2qzuA:
undetectable		 1lbcA-2qzuA:
18.95
1lbcC-2qzuA:
18.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn7 GLUCOAMYLASE

(Trichoderma
reesei) 		PF00686
(CBM_20)
PF00723
(Glyco_hydro_15) 		5 ILE A 158
SER A 152
LEU A 135
SER A 139
LEU A 142
 None
 1.09A 1lbcA-2vn7A:
undetectable
1lbcC-2vn7A:
undetectable		 1lbcA-2vn7A:
18.80
1lbcC-2vn7A:
18.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2zns GLUTAMATE RECEPTOR,
IONOTROPIC KAINATE 1

(Homo sapiens) 		PF10613
(Lig_chan-Glu_bd) 		6 LYS A 516
PRO A 517
MET A 519
LEU A 768
LEU A 776
LYS A 780
 None
 0.84A 1lbcA-2znsA:
37.7
1lbcC-2znsA:
37.9		 1lbcA-2znsA:
52.87
1lbcC-2znsA:
52.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3h6t GLUTAMATE RECEPTOR 2

(Rattus
norvegicus) 		PF10613
(Lig_chan-Glu_bd) 		8 LYS A 104
PRO A 105
MET A 107
SER A 108
LEU A 239
SER A 242
LEU A 247
LYS A 251
 None
CYZ  A 265 (-3.9A)
None
CYZ  A 265 (-2.8A)
CYZ  A 265 (-4.7A)
CYZ  A 265 (-2.9A)
CYZ  A 265 (-4.3A)
CYZ  A 265 ( 4.4A)
 0.37A 1lbcA-3h6tA:
44.1
1lbcC-3h6tA:
43.4		 1lbcA-3h6tA:
100.00
1lbcC-3h6tA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hve GIGAXONIN

(Homo sapiens) 		PF00651
(BTB)
PF07707
(BACK) 		5 ILE A  73
LEU A  48
SER A  52
LEU A 114
LYS A 118
 None
 1.48A 1lbcA-3hveA:
undetectable
1lbcC-3hveA:
undetectable		 1lbcA-3hveA:
22.11
1lbcC-3hveA:
22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nks PROTOPORPHYRINOGEN
OXIDASE

(Homo sapiens) 		PF01593
(Amino_oxidase) 		5 PRO A 287
LEU A 294
SER A 292
LEU A 306
LYS A 429
 None
 1.35A 1lbcA-3nksA:
undetectable
1lbcC-3nksA:
undetectable		 1lbcA-3nksA:
19.96
1lbcC-3nksA:
19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qk3 BETA-CRYSTALLIN B3

(Homo sapiens) 		PF00030
(Crystall) 		5 SER A  71
SER A  98
LEU A  67
LEU A 101
LYS A  55
 None
 1.24A 1lbcA-3qk3A:
undetectable
1lbcC-3qk3A:
undetectable		 1lbcA-3qk3A:
20.53
1lbcC-3qk3A:
20.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2

(Homo sapiens) 		PF10613
(Lig_chan-Glu_bd) 		6 LYS A 500
PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.91A 1lbcA-3qxmA:
37.4
1lbcC-3qxmA:
37.5		 1lbcA-3qxmA:
52.09
1lbcC-3qxmA:
52.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sdq ALPHA-BISABOLENE
SYNTHASE

(Abies grandis) 		PF01397
(Terpene_synth)
PF03936
(Terpene_synth_C) 		5 ILE A 182
LYS A 478
LEU A 133
SER A 129
LEU A 127
 None
 1.44A 1lbcA-3sdqA:
undetectable
1lbcC-3sdqA:
undetectable		 1lbcA-3sdqA:
15.30
1lbcC-3sdqA:
15.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sqz PUTATIVE
HYDROXYMETHYLGLUTARY
L-COA SYNTHASE

(Streptococcus
mutans) 		PF00195
(Chal_sti_synt_N)
PF08540
(HMG_CoA_synt_C) 		5 ILE A 302
SER A 288
LEU A 304
LEU A 234
LYS A 272
 None
 1.46A 1lbcA-3sqzA:
undetectable
1lbcC-3sqzA:
undetectable		 1lbcA-3sqzA:
21.79
1lbcC-3sqzA:
21.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u92 GLUTAMATE RECEPTOR,
IONOTROPIC KAINATE 3

(Rattus
norvegicus) 		PF10613
(Lig_chan-Glu_bd) 		6 LYS A 103
PRO A 104
MET A 106
LEU A 234
LEU A 242
LYS A 246
 None
None
None
None
None
ZN  A 259 (-3.5A)
 0.69A 1lbcA-3u92A:
37.4
1lbcC-3u92A:
37.3		 1lbcA-3u92A:
52.09
1lbcC-3u92A:
52.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zm8 GH26
ENDO-BETA-1,4-MANNAN
ASE

(Podospora
anserina) 		PF02156
(Glyco_hydro_26)
PF16990
(CBM_35) 		5 ILE A 223
SER A 156
PRO A 292
LEU A 294
LEU A 142
 None
 1.25A 1lbcA-3zm8A:
undetectable
1lbcC-3zm8A:
undetectable		 1lbcA-3zm8A:
19.75
1lbcC-3zm8A:
19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fs7 UNCHARACTERIZED
PROTEIN

(Bacteroides
ovatus) 		PF13306
(LRR_5) 		5 ILE A 151
PRO A 190
SER A 192
LEU A 196
LYS A 217
 None
 1.40A 1lbcA-4fs7A:
undetectable
1lbcC-4fs7A:
undetectable		 1lbcA-4fs7A:
21.21
1lbcC-4fs7A:
21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ux3 MITOTIC CHROMOSOME
DETERMINANT-RELATED
PROTEIN
STRUCTURAL
MAINTENANCE OF
CHROMOSOMES PROTEIN
3

(Saccharomyces
cerevisiae) 		PF02463
(SMC_N)
PF04825
(Rad21_Rec8_N) 		5 ILE A1030
LYS A1034
SER B  54
LEU A 179
LEU B  68
 None
 1.03A 1lbcA-4ux3A:
undetectable
1lbcC-4ux3A:
undetectable		 1lbcA-4ux3A:
19.78
1lbcC-4ux3A:
19.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wxj GLUTAMATE RECEPTOR
IIB,GLUTAMATE
RECEPTOR IIB

(Drosophila
melanogaster) 		PF10613
(Lig_chan-Glu_bd) 		5 PRO A 112
MET A 114
LEU A 245
SER A 248
LEU A 253
 None
 0.73A 1lbcA-4wxjA:
37.1
1lbcC-4wxjA:
37.0		 1lbcA-4wxjA:
40.36
1lbcC-4wxjA:
40.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5dtb CG3822

(Drosophila
melanogaster) 		PF10613
(Lig_chan-Glu_bd) 		5 PRO A 109
MET A 111
LEU A 242
LEU A 250
LYS A 254
 None
 0.72A 1lbcA-5dtbA:
38.6
1lbcC-5dtbA:
38.8		 1lbcA-5dtbA:
54.14
1lbcC-5dtbA:
54.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gzg GALECTIN-8

(Homo sapiens) 		PF00337
(Gal-bind_lectin) 		5 ILE A 149
SER A 152
PRO A  24
LEU A 138
LEU A  27
 None
 1.44A 1lbcA-5gzgA:
undetectable
1lbcC-5gzgA:
undetectable		 1lbcA-5gzgA:
20.91
1lbcC-5gzgA:
20.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ict GLUTAMATE RECEPTOR 1

(Drosophila
melanogaster) 		PF10613
(Lig_chan-Glu_bd) 		5 LYS A 110
PRO A 111
MET A 113
LEU A 244
LEU A 252
 None
 0.92A 1lbcA-5ictA:
39.8
1lbcC-5ictA:
39.9		 1lbcA-5ictA:
56.34
1lbcC-5ictA:
56.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ikb GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
4,GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
4

(Rattus
norvegicus) 		PF10613
(Lig_chan-Glu_bd) 		6 LYS A 103
PRO A 104
MET A 106
LEU A 235
LEU A 243
LYS A 247
 None
 0.88A 1lbcA-5ikbA:
36.9
1lbcC-5ikbA:
36.8		 1lbcA-5ikbA:
55.73
1lbcC-5ikbA:
55.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ix1 MORC FAMILY CW-TYPE
ZINC FINGER PROTEIN
3

(Mus musculus) 		PF07496
(zf-CW)
PF13589
(HATPase_c_3) 		5 ILE A 138
SER A 173
PRO A 146
LEU A 135
SER A 131
 None
 1.18A 1lbcA-5ix1A:
undetectable
1lbcC-5ix1A:
undetectable		 1lbcA-5ix1A:
21.93
1lbcC-5ix1A:
21.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5l1b GLUTAMATE RECEPTOR
2,GLUTAMATE RECEPTOR
2

(Rattus
norvegicus) 		PF00060
(Lig_chan)
PF01094
(ANF_receptor)
PF10613
(Lig_chan-Glu_bd) 		7 LYS A 493
PRO A 494
MET A 496
LEU A 751
SER A 754
LEU A 759
LYS A 763
 None
 0.64A 1lbcA-5l1bA:
22.5
1lbcC-5l1bA:
22.4		 1lbcA-5l1bA:
34.90
1lbcC-5l1bA:
34.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5l1b GLUTAMATE RECEPTOR
2,GLUTAMATE RECEPTOR
2

(Rattus
norvegicus) 		PF00060
(Lig_chan)
PF01094
(ANF_receptor)
PF10613
(Lig_chan-Glu_bd) 		7 LYS A 493
PRO A 494
MET A 496
SER A 497
SER A 754
LEU A 759
LYS A 763
 None
 0.60A 1lbcA-5l1bA:
22.5
1lbcC-5l1bA:
22.4		 1lbcA-5l1bA:
34.90
1lbcC-5l1bA:
34.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5wel CHIMERA OF GLUTAMATE
RECEPTOR 2, GERM
CELL-SPECIFIC GENE
1-LIKE PROTEIN

(Mus musculus;
Rattus
norvegicus) 		PF00060
(Lig_chan)
PF01094
(ANF_receptor)
PF07803
(GSG-1)
PF10613
(Lig_chan-Glu_bd) 		7 LYS A 493
PRO A 494
MET A 496
SER A 497
LEU A 751
SER A 754
LEU A 759
 None
 0.90A 1lbcA-5welA:
32.7
1lbcC-5welA:
32.3		 1lbcA-5welA:
34.03
1lbcC-5welA:
34.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5wel CHIMERA OF GLUTAMATE
RECEPTOR 2, GERM
CELL-SPECIFIC GENE
1-LIKE PROTEIN

(Mus musculus;
Rattus
norvegicus) 		PF00060
(Lig_chan)
PF01094
(ANF_receptor)
PF07803
(GSG-1)
PF10613
(Lig_chan-Glu_bd) 		7 LYS A 493
PRO A 494
SER A 497
LEU A 751
SER A 754
LEU A 759
LYS A 763
 None
 1.22A 1lbcA-5welA:
32.7
1lbcC-5welA:
32.3		 1lbcA-5welA:
34.03
1lbcC-5welA:
34.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5weo GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT
CHIMERA

(Mus musculus;
Rattus
norvegicus) 		PF00060
(Lig_chan)
PF00822
(PMP22_Claudin)
PF01094
(ANF_receptor)
PF10613
(Lig_chan-Glu_bd) 		5 LYS A 493
MET A 496
SER A 497
LEU A 751
LEU A 759
 None
CYZ  A1302 (-4.3A)
CYZ  A1302 (-3.2A)
None
None
 0.66A 1lbcA-5weoA:
25.1
1lbcC-5weoA:
25.0		 1lbcA-5weoA:
34.03
1lbcC-5weoA:
34.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5weo GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT
CHIMERA

(Mus musculus;
Rattus
norvegicus) 		PF00060
(Lig_chan)
PF00822
(PMP22_Claudin)
PF01094
(ANF_receptor)
PF10613
(Lig_chan-Glu_bd) 		5 LYS A 493
MET A 496
SER A 497
LEU A 759
LYS A 763
 None
CYZ  A1302 (-4.3A)
CYZ  A1302 (-3.2A)
None
CYZ  A1302 (-2.9A)
 1.20A 1lbcA-5weoA:
25.1
1lbcC-5weoA:
25.0		 1lbcA-5weoA:
34.03
1lbcC-5weoA:
34.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5weo GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT
CHIMERA

(Mus musculus;
Rattus
norvegicus) 		PF00060
(Lig_chan)
PF00822
(PMP22_Claudin)
PF01094
(ANF_receptor)
PF10613
(Lig_chan-Glu_bd) 		5 LYS A 493
MET A 496
SER A 754
LEU A 759
LYS A 763
 None
CYZ  A1302 (-4.3A)
CYZ  A1302 ( 4.1A)
None
CYZ  A1302 (-2.9A)
 1.16A 1lbcA-5weoA:
25.1
1lbcC-5weoA:
25.0		 1lbcA-5weoA:
34.03
1lbcC-5weoA:
34.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5weo GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT
CHIMERA

(Mus musculus;
Rattus
norvegicus) 		PF00060
(Lig_chan)
PF00822
(PMP22_Claudin)
PF01094
(ANF_receptor)
PF10613
(Lig_chan-Glu_bd) 		5 LYS A 493
PRO A 494
MET A 496
SER A 497
LEU A 751
 None
CYZ  A1302 (-4.5A)
CYZ  A1302 (-4.3A)
CYZ  A1302 (-3.2A)
None
 0.65A 1lbcA-5weoA:
25.1
1lbcC-5weoA:
25.0		 1lbcA-5weoA:
34.03
1lbcC-5weoA:
34.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yay KN MOTIF AND ANKYRIN
REPEAT DOMAINS 1

(Mus musculus) 		no annotation 5 ILE A1255
SER A1251
LYS A1259
LEU A1293
LEU A1246
 None
 1.43A 1lbcA-5yayA:
undetectable
1lbcC-5yayA:
undetectable		 1lbcA-5yayA:
16.02
1lbcC-5yayA:
16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zal ENDORIBONUCLEASE
DICER

(Homo sapiens) 		no annotation 5 SER A1737
PRO A1850
SER A1852
LEU A1841
LEU A1735
 None
 1.27A 1lbcA-5zalA:
undetectable
1lbcC-5zalA:
undetectable		 1lbcA-5zalA:
13.08
1lbcC-5zalA:
13.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ank SYNAPTOTAGMIN-7

(Rattus
norvegicus) 		PF00168
(C2) 		5 LYS A 176
SER A 239
LEU A 224
LEU A 257
LYS A 255
 None
 1.50A 1lbcA-6ankA:
undetectable
1lbcC-6ankA:
undetectable		 1lbcA-6ankA:
21.54
1lbcC-6ankA:
21.54